Casimir Further Differentiates Emmes’ Industry-Leading Rare Disease Research Capabilities Rockville, MD, March 10, 2022 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company…
Continuation Fund Provides Incremental Capital to Accelerate Growth and Support Future M&A New York, NY, February 28, 2022 – Behrman Capital, a private equity investment firm based in New York, today announced the closing of Behrman Capital Micross CF L.P.,…
Third Add-on Acquisition Under Behrman’s Ownership Expands European Presence in Germany; Adds New Electronic Data Capture Tool to Enhance Real World Evidence Research Rockville, MD, December 21, 2021 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated…
New York, November 3, 2021 – Behrman Capital, a private equity investment firm based in New York, today announced the sale of its portfolio company BECO Holding Company, Inc. (“BHC” or the “Company”) to an affiliate of H.I.G. Capital. Financial…
Second acquisition under Behrman ownership enhances Waterline’s portfolio of trenchless pipeline rehabilitation solutions for the wastewater industry in North America ELK GROVE VILLAGE, IL, November 2, 2021 – Waterline Renewal Technologies, a portfolio company of Behrman Capital, today announced the…
New York, October 19, 2021 – Behrman Capital, a private equity investment firm based in New York, today announced that it has reached a definitive agreement to sell its portfolio company Pelican Products, Inc. (the “Company”), including the Peli BioThermal…
New York, July 7, 2021 – Behrman Capital (“Behrman”), a private equity investment firm based in New York, today announced that it has acquired Shur-Co, LLC (“Shur-Co” or the “Company”), a leading manufacturer of innovative cargo covering and cargo control…
Orlando, FL - July 1, 2021 – Micross Components (“Micross” or the “Company”), a leading provider of high-reliability microelectronic product and service solutions for aerospace, defense, space, medical and industrial applications and a portfolio company of Behrman Capital, announced the…
Second Add-on Acquisition Under Behrman’s Ownership Further Expands Emmes’ European Footprint and Market-Leading Capabilities in Rare Diseases Rockville, MD, May 11, 2021 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public…
Transaction Expands Emmes’ BioPharma Effort and European Presence Rockville, MD – December 30, 2020 – The Emmes Company, LLC (“Emmes”), a full-service clinical research organization (CRO) dedicated to supporting the advancement of human health and biopharmaceutical innovation and a portfolio…